Form 4 Tracker
Robin Lachapelle

Chief Operating Officer · 1 filing · Latest: Feb 2, 2026

ArriVent BioPharma, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing